agar well diffusion method (Biopharm GmbH)
90
Structured Review
Biopharm GmbH
agar well diffusion method
Agar Well Diffusion Method, supplied by Biopharm GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/agar+well-diffusion+method/agar+well+diffusion+method/pm26047797-151-11-0
Average 90 stars, based on 1 article reviews
Agar Well Diffusion Method, supplied by Biopharm GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/agar+well-diffusion+method/agar+well+diffusion+method/pm26047797-151-11-0
Average 90 stars, based on 1 article reviews
agar well diffusion method - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Isolation:Article Title: Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment. Article Snippet: In-situ forming implant formulations based on poly(lactic-co-glycolic acid) (PLGA), acetyltributyl citrate (ATBC), minocycline HCl, N-methyl pyrrolidone (NMP) and optionally hydroxypropyl methylcellulose (HPMC) were prepared and thoroughly characterized in vitro.. This includes electron paramagnetic resonance (EPR), nuclear magnetic resonance (H NMR), mass change and drug release measurements under different conditions, optical microscopy, size exclusion chromatography (SEC) as well as antibacterial activity tests using gingival crevicular fluid samples from periodontal pockets of periodontitis patients.. Based on these results, deeper insight into the physico-chemical phenomena involved in implant formation and the control of drug release could be gained. Diffusion-based Assay:Article Title: Mechanistic analysis of PLGA/HPMC-based in-situ forming implants for periodontitis treatment. Article Snippet: In-situ forming implant formulations based on poly(lactic-co-glycolic acid) (PLGA), acetyltributyl citrate (ATBC), minocycline HCl, N-methyl pyrrolidone (NMP) and optionally hydroxypropyl methylcellulose (HPMC) were prepared and thoroughly characterized in vitro.. This includes electron paramagnetic resonance (EPR), nuclear magnetic resonance (H NMR), mass change and drug release measurements under different conditions, optical microscopy, size exclusion chromatography (SEC) as well as antibacterial activity tests using gingival crevicular fluid samples from periodontal pockets of periodontitis patients.. Based on these results, deeper insight into the physico-chemical phenomena involved in implant formation and the control of drug release could be gained. |
![Antibacterial activity of TiNts, [Eu(tta) 3 phen], TiNtsTi/Eu and TiNts[Eu(tta) 3 phen] against S. aureus ATCC 25923 and E. coli ATCC 25922. Note: 1 (3 mg mL –1 ), 2 (6 mg mL –1 ), 3 (12 mg mL –1 ), 4 (25 mg mL –1 ). B, corresponds to the negative control (sterilized deionized water); C, corresponds to the gentamicin (10 μg). All tests were performed in triplicate for each bacterium.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6813/pmc12756813/pmc12756813__ao5c08930_0007.jpg)
![Antibacterial activity of TiNts[Eu(tta) 3 phen] against S. aureus ATCC 25923 and E. coli ATCC 25922. Note: 1 (6 mg mL –1 ), 2 (12 mg mL –1 ), 3 (25 mg mL –1 ), 4 (50 mg mL –1 ), 5 (100 mg mL –1 ).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6813/pmc12756813/pmc12756813__ao5c08930_0008.jpg)